|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 213/75 | |
| A61K 31/44 | |||
| A61P 7/00 |
| (11) | Patento numeris | 2513058 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10801495.2 |
| Europos patento paraiškos padavimo data | 2010-12-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-10-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-11-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/060572 |
| Data | 2010-12-15 |
| (87) | Numeris | WO 2011/084519 |
| Data | 2011-07-14 |
| (30) | Numeris | Data | Šalis |
| 287680 P | 2009-12-17 | US |
| (72) |
PANDEY, Anjali, US
LEITAO, Emilia, P., T., PT
RATO, Jose, PT
SONG, Zhiguo, Jake, US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
Portola Pharmaceuticals, Inc., 270 East Grand Avenue Suite 22, South San Francisco, California 94080, US |
| (54) | METHODS OF SYNTHESIZING FACTOR XA INHIBITORS |
| METHODS OF SYNTHESIZING FACTOR XA INHIBITORS |